CD44 and cancer: CD44 has been widely used as a putative CSC marker in a wide range of cancer types including CRC because the CD44high population exhibits distinct CSC phenotypes such as the ability to initiate tumourigenesis after low‐density translation into immune‐deficient mice, the ability to recapitulate the original tumour heterogeneity and the ability to grow as floating spheres.59